Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study.

Michael James OvermanFabio GelsominoMassimo AgliettaMark WongMaria Luisa Limon MironGregory LeonardPilar García-AlfonsoAndrew G HillAntonio Cubillo GracianEric Van CutsemBassel El-RayesStephen M McCraithBeilei HeMing LeiSara Lonardi

Published in: Journal for immunotherapy of cancer (2024)

NCT02060188.

Keyphrases

phase ii
metastatic colorectal cancer
clinical trial
open label
phase iii
placebo controlled
newly diagnosed